Caris Life Sciences, Inc. (CAI) experienced a pre-market plunge of 9.83% on Friday, following the release of its quarterly earnings results.
Despite reporting breakeven earnings per share for the quarter, which beat analyst expectations of a 2-cent loss, and revenue of $216.17 million that exceeded forecasts, investor sentiment turned negative. The company reported a quarterly loss of $510 thousand, and market attention has been drawn to significant downward revisions in analyst earnings estimates over the past three months, which fell by approximately 146.6%.
The sharp decline in pre-market trading suggests that investors are focusing on the underlying loss and the trend of reduced expectations, even as the company surpassed the lowered consensus figures for the latest quarter.
Comments